Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ460460,50,55
KB6146151,82
PKN57,4657,53,64
Msft0,06
Nokia3,2543,28-1,07
IBM2,90
Daimler AG57,8258,212,54
PFE0,62
05.12.2020 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 04.12.2020 16:16:26
Novozymes (NZM2b.F, Frankfurt)
Závěr k 4.12.2020 Změna (%) Změna (EUR) Objem obchodů (EUR)
46,00 0,15 0,07 10 588
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 05.12.2020
Popis společnosti
Obecné informace
Název společnostiNovozymes A/S
TickerNZYM B
Kmenové akcie:Ordinary Shares Class B
Kmenové akcie:Ordinary Shares
RICNZYMb.CO
ISINDK0060336014
Poslední známé roční výsledky31.12.2019
Poslední známé čtvrtletní výsledky30.09.2020
Počet zaměstnanců k 30.09.2020 6 180
Akcie v oběhu k 30.09.2020 279 122 221
MěnaDKK
Kontaktní informace
UliceKrogshoejvej 36
MěstoBAGSVAERD
PSČ2880
ZeměDenmark
Kontatní osobaTobias Bjorklund
Funkce kontaktní osobyHead of Investor Relations
Telefon4 544 460 000
Fax4544469999
Kontatní telefon4 530 778 682

Business Summary: Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.
Financial Summary: BRIEF: For the nine months ended 30 September 2020,Novozymes A/S revenues decreased 1% to DKR10.57B. Netincome decreased 3% to DKR2.17B. Revenues reflect Bioenergysegment decrease of 14% to DKR1.76B, Technical & Pharmasegment decrease of 19% to DKR459M, North America segmentdecrease of 5% to DKR3.34B, Asia Pacific segment decreaseof 3% to DKR2.06B. Net income also reflects OperatingCosts/Income decrease of 89% to DKR53M (income).
Odvětvová klasifikace
TRBC2009Chemicals - Commodity
TRBC2012Industrial Biotechnology Chemicals
RBSS2004Chemicals - Commodity
MGINDUSTRYChemical Manufacturing
MGSECTORBasic Materials
NAICS2007All Other Basic Organic Chemical Mfg
NAICS1997All Other Basic Organic Chemical Manufacturing
SICIndustrial Organic Chemicals, Nec



  • Poslední aktualizace: 05.12.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the BoardJoergen Buhl Rasmussen6522.02.201724.02.2016
President, Chief Executive OfficerEster Baiget-01.02.202001.02.2020
Chief Financial Officer, Executive Vice President - Finance, IT & LegalLars Green5201.09.201901.09.2019
Executive Vice President, Household Care & Technical IndustriesAnders Lund4708.02.201608.02.2016
Executive Vice President - People, Sustainability and BrandMorten Rasmussen-01.04.202101.04.2021
Executive Vice President, Interim Head of People & Organization, Sustainability and Branding, Interim Head of Strategy and BusinThomas Videbaek5901.09.2020
Executive Vice President - Strategy and Business TransformationAmy Byrick-
Executive Vice President, Food & BeveragesAndrew Fordyce5708.02.201601.04.2013
Executive Vice President, Agriculture & BioenergyTina Sejersgaard Fanoe5108.02.201608.02.2016